 | • レポートコード：20QY06-04912 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、乾燥粉末吸入器のグローバル市場について種類別（単回投与、複数回投与）、用途別（喘息、COPD、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・乾燥粉末吸入器市場の概要 ・世界の主要地域別乾燥粉末吸入器市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の乾燥粉末吸入器市場規模2015-2026：種類別（単回投与、複数回投与） ・世界の乾燥粉末吸入器市場規模2015-2026：用途別（喘息、COPD、その他） ・乾燥粉末吸入器の北米市場規模2015-2020 ・乾燥粉末吸入器のヨーロッパ市場規模2015-2020 ・乾燥粉末吸入器の中国市場規模2015-2020 ・乾燥粉末吸入器の日本市場規模2015-2020 ・乾燥粉末吸入器の東南アジア市場規模2015-2020 ・乾燥粉末吸入器のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （GlaxoSmithKline、AstraZeneca、Boehringer Ingelheim、Chiesi、Cipla、3M、Hovione、Mannkind、Mylan、Novartis、Schering/Merck、Teva、Vectura） ・乾燥粉末吸入器の製造コスト分析 ・販売チャネル、流通業者、顧客 ・乾燥粉末吸入器の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Dry Powder Inhaler Device Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Dry Powder Inhaler Device market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Dry Powder Inhaler Device market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Dry Powder Inhaler Device industry.
Based on our recent survey, we have several different scenarios about the Dry Powder Inhaler Device YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 712.1 million in 2019. The market size of Dry Powder Inhaler Device will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Dry Powder Inhaler Device market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Dry Powder Inhaler Device market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Dry Powder Inhaler Device market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Dry Powder Inhaler Device market. The report also includes nautical information, where it shows Dry Powder Inhaler Device market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Dry Powder Inhaler Device market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Dry Powder Inhaler Device market.
The global total sales of dry powder inhaler device is nearly 49674 K units in 2015.
Geographical Analysis:
Based on region, the global Dry Powder Inhaler Device market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Dry Powder Inhaler Device market are
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Segment by Type
Single Dose
Multi-dose
Segment by Application
Asthma
COPD
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Dry Powder Inhaler Device market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Dry Powder Inhaler Device market.
• The market share of the global Dry Powder Inhaler Device market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Dry Powder Inhaler Device market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Dry Powder Inhaler Device market.
1 Dry Powder Inhaler Device Market Overview
1.1 Dry Powder Inhaler Device Product Scope
1.2 Dry Powder Inhaler Device Segment by Type
1.2.1 Global Dry Powder Inhaler Device Sales by Type (2020-2026)
1.2.2 Single Dose
1.2.3 Multi-dose
1.3 Dry Powder Inhaler Device Segment by Application
1.3.1 Global Dry Powder Inhaler Device Sales Comparison by Application (2020-2026)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Other
1.4 Dry Powder Inhaler Device Market Estimates and Forecasts (2015-2026)
1.4.1 Global Dry Powder Inhaler Device Sales Growth Rate (2015-2026)
1.4.2 Global Dry Powder Inhaler Device Revenue and Growth Rate (2015-2026)
1.4.3 Global Dry Powder Inhaler Device Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Dry Powder Inhaler Device Industry Impact
1.5.1 How the Covid-19 is Affecting the Dry Powder Inhaler Device Industry
1.5.1.1 Dry Powder Inhaler Device Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Dry Powder Inhaler Device Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Dry Powder Inhaler Device Players to Combat Covid-19 Impact
2 Dry Powder Inhaler Device Estimate and Forecast by Region
2.1 Global Dry Powder Inhaler Device Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Dry Powder Inhaler Device Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Dry Powder Inhaler Device Sales Market Share by Region (2015-2020)
2.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Region (2015-2020)
2.3 Global Dry Powder Inhaler Device Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Dry Powder Inhaler Device Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Dry Powder Inhaler Device Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Dry Powder Inhaler Device Estimates and Projections (2015-2026)
2.4.2 Europe Dry Powder Inhaler Device Estimates and Projections (2015-2026)
2.4.3 China Dry Powder Inhaler Device Estimates and Projections (2015-2026)
2.4.4 Japan Dry Powder Inhaler Device Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Dry Powder Inhaler Device Estimates and Projections (2015-2026)
2.4.6 India Dry Powder Inhaler Device Estimates and Projections (2015-2026)
3 Global Dry Powder Inhaler Device Competition Landscape by Players
3.1 Global Top Dry Powder Inhaler Device Players by Sales (2015-2020)
3.2 Global Top Dry Powder Inhaler Device Players by Revenue (2015-2020)
3.3 Global Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Powder Inhaler Device as of 2019)
3.4 Global Dry Powder Inhaler Device Average Price by Company (2015-2020)
3.5 Manufacturers Dry Powder Inhaler Device Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Dry Powder Inhaler Device Players (Opinion Leaders)
4 Global Dry Powder Inhaler Device Market Size by Type
4.1 Global Dry Powder Inhaler Device Historic Market Review by Type (2015-2020)
4.1.1 Global Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
4.1.2 Global Dry Powder Inhaler Device Revenue Market Share by Type (2015-2020)
4.1.3 Global Dry Powder Inhaler Device Price by Type (2014-2020)
4.2 Global Dry Powder Inhaler Device Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Dry Powder Inhaler Device Sales Forecast by Type (2021-2026)
4.2.2 Global Dry Powder Inhaler Device Revenue Forecast by Type (2021-2026)
4.2.3 Global Dry Powder Inhaler Device Price Forecast by Type (2021-2026)
5 Global Dry Powder Inhaler Device Market Size by Application
5.1 Global Dry Powder Inhaler Device Historic Market Review by Application (2015-2020)
5.1.1 Global Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
5.1.2 Global Dry Powder Inhaler Device Revenue Market Share by Application (2015-2020)
5.1.3 Global Dry Powder Inhaler Device Price by Application (2015-2020)
5.2 Global Dry Powder Inhaler Device Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Dry Powder Inhaler Device Sales Forecast by Application (2021-2026)
5.2.2 Global Dry Powder Inhaler Device Revenue Forecast by Application (2021-2026)
5.2.3 Global Dry Powder Inhaler Device Price Forecast by Application (2021-2026)
3 North America Dry Powder Inhaler Device Market Facts & Figures
3.2 North America Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
3.3 North America Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
3.4 North America Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
4 Europe Dry Powder Inhaler Device Market Facts & Figures
4.2 Europe Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
4.3 Europe Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
4.4 Europe Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
5 China Dry Powder Inhaler Device Market Facts & Figures
5.2 China Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
5.3 China Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
5.4 China Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
6 Japan Dry Powder Inhaler Device Market Facts & Figures
6.2 Japan Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
6.3 Japan Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
6.4 Japan Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
7 Southeast Asia Dry Powder Inhaler Device Market Facts & Figures
7.2 Southeast Asia Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
8 India Dry Powder Inhaler Device Market Facts & Figures
8.2 India Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
8.3 India Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
8.4 India Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Dry Powder Inhaler Device Business
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Dry Powder Inhaler Device Corporation Information
12.1.2 GlaxoSmithKline Dry Powder Inhaler Device Business Overview and Total Revenue
12.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Dry Powder Inhaler Device Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Dry Powder Inhaler Device Corporation Information
12.2.2 AstraZeneca Dry Powder Inhaler Device Business Overview and Total Revenue
12.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AstraZeneca Dry Powder Inhaler Device Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Dry Powder Inhaler Device Corporation Information
12.3.2 Boehringer Ingelheim Dry Powder Inhaler Device Business Overview and Total Revenue
12.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Chiesi
12.4.1 Chiesi Dry Powder Inhaler Device Corporation Information
12.4.2 Chiesi Dry Powder Inhaler Device Business Overview and Total Revenue
12.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Chiesi Dry Powder Inhaler Device Products Offered
12.4.5 Chiesi Recent Development
12.5 Cipla
12.5.1 Cipla Dry Powder Inhaler Device Corporation Information
12.5.2 Cipla Dry Powder Inhaler Device Business Overview and Total Revenue
12.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Cipla Dry Powder Inhaler Device Products Offered
12.5.5 Cipla Recent Development
12.6 3M
12.6.1 3M Dry Powder Inhaler Device Corporation Information
12.6.2 3M Dry Powder Inhaler Device Business Overview and Total Revenue
12.6.3 3M Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.6.4 3M Dry Powder Inhaler Device Products Offered
12.6.5 3M Recent Development
12.7 Hovione
12.7.1 Hovione Dry Powder Inhaler Device Corporation Information
12.7.2 Hovione Dry Powder Inhaler Device Business Overview and Total Revenue
12.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hovione Dry Powder Inhaler Device Products Offered
12.7.5 Hovione Recent Development
12.8 Mannkind
12.8.1 Mannkind Dry Powder Inhaler Device Corporation Information
12.8.2 Mannkind Dry Powder Inhaler Device Business Overview and Total Revenue
12.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Mannkind Dry Powder Inhaler Device Products Offered
12.8.5 Mannkind Recent Development
12.9 Mylan
12.9.1 Mylan Dry Powder Inhaler Device Corporation Information
12.9.2 Mylan Dry Powder Inhaler Device Business Overview and Total Revenue
12.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Mylan Dry Powder Inhaler Device Products Offered
12.9.5 Mylan Recent Development
12.10 Novartis
12.10.1 Novartis Dry Powder Inhaler Device Corporation Information
12.10.2 Novartis Dry Powder Inhaler Device Business Overview and Total Revenue
12.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Novartis Dry Powder Inhaler Device Products Offered
12.10.5 Novartis Recent Development
12.11 Schering/Merck
12.11.1 Schering/Merck Dry Powder Inhaler Device Corporation Information
12.11.2 Schering/Merck Dry Powder Inhaler Device Business Overview and Total Revenue
12.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Schering/Merck Dry Powder Inhaler Device Products Offered
12.11.5 Schering/Merck Recent Development
12.12 Teva
12.12.1 Teva Dry Powder Inhaler Device Corporation Information
12.12.2 Teva Dry Powder Inhaler Device Business Overview and Total Revenue
12.12.3 Teva Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Teva Dry Powder Inhaler Device Products Offered
12.12.5 Teva Recent Development
12.13 Vectura
12.13.1 Vectura Dry Powder Inhaler Device Corporation Information
12.13.2 Vectura Dry Powder Inhaler Device Business Overview and Total Revenue
12.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Vectura Dry Powder Inhaler Device Products Offered
12.13.5 Vectura Recent Development
13 Dry Powder Inhaler Device Manufacturing Cost Analysis
13.1 Dry Powder Inhaler Device Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dry Powder Inhaler Device
13.4 Dry Powder Inhaler Device Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dry Powder Inhaler Device Distributors List
14.3 Dry Powder Inhaler Device Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Dry Powder Inhaler Device Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Dry Powder Inhaler Device Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Dry Powder Inhaler Device Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Dry Powder Inhaler Device Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Dry Powder Inhaler Device Players to Combat Covid-19 Impact
Table 8. Global Market Dry Powder Inhaler Device Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Dry Powder Inhaler Device Sales (K Units) by Region (2015-2020)
Table 10. Global Dry Powder Inhaler Device Sales Market Share by Region (2015-2020)
Table 11. Global Dry Powder Inhaler Device Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Dry Powder Inhaler Device Revenue Share by Region (2015-2020)
Table 13. Global Dry Powder Inhaler Device Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Dry Powder Inhaler Device Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Dry Powder Inhaler Device Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Dry Powder Inhaler Device Revenue Share Forecast by Region (2021-2026)
Table 17. Global Dry Powder Inhaler Device (K Units) of Key Companies (2015-2020)
Table 18. Global Dry Powder Inhaler Device Sales Share by Company (2015-2020)
Table 19. Global Dry Powder Inhaler Device Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Dry Powder Inhaler Device Revenue Share by Company (2015-2020)
Table 21. Global Dry Powder Inhaler Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Powder Inhaler Device as of 2019)
Table 22. Global Dry Powder Inhaler Device Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Dry Powder Inhaler Device Manufacturing Sites and Area Served
Table 24. Manufacturers Dry Powder Inhaler Device Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Dry Powder Inhaler Device Players
Table 27. Global Dry Powder Inhaler Device Sales (K Units) by Type (2015-2020)
Table 28. Global Dry Powder Inhaler Device Sales Share by Type (2015-2020)
Table 29. Global Dry Powder Inhaler Device Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Dry Powder Inhaler Device Price (K Units) by Type (2015-2020)
Table 31. Global Dry Powder Inhaler Device Sales Share by Type (2021-2026)
Table 32. Global Dry Powder Inhaler Device Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Dry Powder Inhaler Device Revenue Share by Type (2021-2026)
Table 34. Global Dry Powder Inhaler Device Price (K Units) by Type (2021-2026)
Table 35. Global Dry Powder Inhaler Device Sales (K Units) by Application (2015-2020)
Table 36. Global Dry Powder Inhaler Device Sales Share by Application (2015-2020)
Table 37. Global Dry Powder Inhaler Device Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Dry Powder Inhaler Device Price (K Units) by Application (2015-2020)
Table 39. Global Dry Powder Inhaler Device Sales (K Units) by Application (2021-2026)
Table 40. Global Dry Powder Inhaler Device Sales Share by Application (2021-2026)
Table 41. Global Dry Powder Inhaler Device Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Dry Powder Inhaler Device Revenue Share by Application (2021-2026)
Table 43. Global Dry Powder Inhaler Device Price (K Units) by Application (2021-2026)
Table 44. United States Dry Powder Inhaler Device Sales (K Units) by Company (2015-2020)
Table 45. United States Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
Table 46. United States Dry Powder Inhaler Device Sales (K Units) by Type (2015-2020)
Table 47. United States Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
Table 48. United States Dry Powder Inhaler Device Sales (K Units) by Application (2015-2020)
Table 49. United States Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
Table 50. Europe Dry Powder Inhaler Device Sales (K Units) by Company (2015-2020)
Table 51. Europe Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
Table 52. Europe Dry Powder Inhaler Device Sales (K Units) by Type (2015-2020)
Table 53. Europe Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
Table 54. Europe Dry Powder Inhaler Device Sales (K Units) by Application (2015-2020)
Table 55. Europe Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
Table 56. China Dry Powder Inhaler Device Sales (K Units) by Company (2015-2020)
Table 57. China Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
Table 58. China Dry Powder Inhaler Device Sales (K Units) by Type (2015-2020)
Table 59. China Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
Table 60. China Dry Powder Inhaler Device Sales (K Units) by Application (2015-2020)
Table 61. China Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
Table 62. Japan Dry Powder Inhaler Device Sales (K Units) by Company (2015-2020)
Table 63. Japan Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
Table 64. Japan Dry Powder Inhaler Device Sales (K Units) by Type (2015-2020)
Table 65. Japan Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
Table 66. Japan Dry Powder Inhaler Device Sales (K Units) by Application (2015-2020)
Table 67. Japan Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Dry Powder Inhaler Device Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Dry Powder Inhaler Device Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Dry Powder Inhaler Device Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
Table 74. India Dry Powder Inhaler Device Sales (K Units) by Company (2015-2020)
Table 75. India Dry Powder Inhaler Device Sales Market Share by Company (2015-2020)
Table 76. India Dry Powder Inhaler Device Sales (K Units) by Type (2015-2020)
Table 77. India Dry Powder Inhaler Device Sales Market Share by Type (2015-2020)
Table 78. India Dry Powder Inhaler Device Sales (K Units) by Application (2015-2020)
Table 79. India Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline Dry Powder Inhaler Device Product
Table 84. GlaxoSmithKline Recent Development
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. AstraZeneca Dry Powder Inhaler Device Product
Table 89. AstraZeneca Recent Development
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Business Overview
Table 92. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Dry Powder Inhaler Device Product
Table 94. Boehringer Ingelheim Recent Development
Table 95. Chiesi Corporation Information
Table 96. Chiesi Description and Business Overview
Table 97. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Chiesi Dry Powder Inhaler Device Product
Table 99. Chiesi Recent Development
Table 100. Cipla Corporation Information
Table 101. Cipla Description and Business Overview
Table 102. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Cipla Dry Powder Inhaler Device Product
Table 104. Cipla Recent Development
Table 105. 3M Corporation Information
Table 106. 3M Description and Business Overview
Table 107. 3M Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. 3M Dry Powder Inhaler Device Product
Table 109. 3M Recent Development
Table 110. Hovione Corporation Information
Table 111. Hovione Description and Business Overview
Table 112. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Hovione Dry Powder Inhaler Device Product
Table 114. Hovione Recent Development
Table 115. Mannkind Corporation Information
Table 116. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Mannkind Description and Business Overview
Table 118. Mannkind Dry Powder Inhaler Device Product
Table 119. Mannkind Recent Development
Table 120. Mylan Corporation Information
Table 121. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Mylan Description and Business Overview
Table 123. Mylan Dry Powder Inhaler Device Product
Table 124. Mylan Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Novartis Dry Powder Inhaler Device Product
Table 129. Novartis Recent Development
Table 130. Schering/Merck Corporation Information
Table 131. Schering/Merck Description and Business Overview
Table 132. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Schering/Merck Dry Powder Inhaler Device Product
Table 134. Schering/Merck Recent Development
Table 135. Teva Corporation Information
Table 136. Teva Description and Business Overview
Table 137. Teva Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Teva Dry Powder Inhaler Device Product
Table 139. Teva Recent Development
Table . Vectura Corporation Information
Table . Vectura Description and Business Overview
Table . Vectura Dry Powder Inhaler Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Vectura Dry Powder Inhaler Device Product
Table . Vectura Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Dry Powder Inhaler Device Distributors List
Table 148. Dry Powder Inhaler Device Customers List
Table 149. Market Key Trends
Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 151. Key Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Dry Powder Inhaler Device Product Picture
Figure 2. Global Dry Powder Inhaler Device Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dry Powder Inhaler Device Market Share by Application in 2020 & 2026
Figure 6. Asthma Examples
Figure 7. COPD Examples
Figure 8. Other Examples
Figure 9. Global Dry Powder Inhaler Device Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Dry Powder Inhaler Device Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Dry Powder Inhaler Device Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Dry Powder Inhaler Device Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Dry Powder Inhaler Device Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Dry Powder Inhaler Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Dry Powder Inhaler Device Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Dry Powder Inhaler Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Dry Powder Inhaler Device Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Dry Powder Inhaler Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Dry Powder Inhaler Device Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Dry Powder Inhaler Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Dry Powder Inhaler Device Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Dry Powder Inhaler Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Dry Powder Inhaler Device Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Dry Powder Inhaler Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Dry Powder Inhaler Device Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Dry Powder Inhaler Device Players Market Share by Revenue in Dry Powder Inhaler Device 2015 & 2019
Figure 27. Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Dry Powder Inhaler Device Revenue Share by Type (2015-2020)
Figure 29. Global Dry Powder Inhaler Device Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Dry Powder Inhaler Device Revenue Share by Application (2015-2020)
Figure 31. Global Dry Powder Inhaler Device Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Dry Powder Inhaler Device Sales Market Share by Type in 2019
Figure 33. United States Dry Powder Inhaler Device Sales Market Share by Type in 2019
Figure 34. Europe Dry Powder Inhaler Device Sales Market Share by Company in 2019
Figure 35. Europe Dry Powder Inhaler Device Sales Market Share by Type in 2019
Figure 36. Europe Dry Powder Inhaler Device Sales Market Share by Application in 2019
Figure 37. China Dry Powder Inhaler Device Sales Market Share by Company in 2019
Figure 38. China Dry Powder Inhaler Device Sales Market Share by Type in 2019
Figure 39. China Dry Powder Inhaler Device Sales Market Share by Application in 2019
Figure 40. Japan Dry Powder Inhaler Device Sales Market Share by Company in 2019
Figure 41. Japan Dry Powder Inhaler Device Sales Market Share by Type in 2019
Figure 42. Japan Dry Powder Inhaler Device Sales Market Share by Application in 2019
Figure 43. Southeast Asia Dry Powder Inhaler Device Sales Market Share by Company in 2019
Figure 44. Southeast Asia Dry Powder Inhaler Device Sales Market Share by Type in 2019
Figure 45. Southeast Asia Dry Powder Inhaler Device Sales Market Share by Application in 2019
Figure 46. India Dry Powder Inhaler Device Sales Market Share by Company in 2019
Figure 47. India Dry Powder Inhaler Device Sales Market Share by Type in 2019
Figure 48. India Dry Powder Inhaler Device Sales Market Share by Application in 2019
Figure 49. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Chiesi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. 3M Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Hovione Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Mannkind Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Schering/Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Vectura Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Dry Powder Inhaler Device
Figure 64. Manufacturing Process Analysis of Dry Powder Inhaler Device
Figure 65. Dry Powder Inhaler Device Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
定量吸入器デバイスの世界市場レポート2020 Market Analysis and Insights: Global Metered Dose Inhaler Devices Market The global Metered Dose Inhaler Devices market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Metered Dose Inhaler Devices Scope and Mark…- 加圧式定量吸入器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pressurized Metered Dose Inhaler market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pressurized …
- 呼吸作動式加圧吸入器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Breath-actuated Pressurized Inhaler market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breath-ac…
- スマート吸入器技術の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Smart Inhaler Technology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Smart Inhaler Techno…
- ナノ磁気デバイスの世界市場レポート2020 Market Analysis and Insights: Global Nano-magnetic Device Market The global Nano-magnetic Device market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Nano-magnetic Device Scope and Market Size The global Nano-…